29 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
) and postpone the advancement of all pre-clinical and discovery programs. The Company’s overall partnership strategy remains unchanged and the Company
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
5 Jun 23
Current report (foreign)
4:28pm
financial condition, results of operations, business strategy and plans, prospective products and their potential benefits, product approvals … of operations, business strategy and financial needs. These forward-looking statements are inherently subject to a number of risks, uncertainties
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
1 Jun 23
Current report (foreign)
4:24pm
upon discontinuation and high potency, there is an opportunity to optimize the dosing strategy in future trials to further enhance the already
6-K
EX-99.1
uclc9 2knqo2ap
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
F-3/A
yp5c7kvu6l5 zry
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
54f24by6 s3lf8kkmp2p
10 Jun 22
Current report (foreign)
6:05am
F-3/A
svd8eb h7tg1
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
6qtro1 xmy92o6
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
ajiinedx6 wv
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
ctzi1
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
tdk56aal83nrqya
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
c4z3kdg
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
2uf1nj2cowf0h8m9
16 Feb 22
Current report (foreign)
4:01pm
6-K
EX-99.2
a4beby 3ph
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.3
miv ztkm3tg
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
ysaqzsoja5we0gfee
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
424B4
3btc3hxkz3dp7 f1
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
h99er0pnr0z88aj u9
18 Mar 21
Registration statement (foreign) (amended)
6:15am